Showing posts with label TRAIL. Show all posts
Showing posts with label TRAIL. Show all posts
Tuesday, July 20, 2010
Overcoming TRAIL resistance in ovarian carcinoma
CONCLUSION: Continued efforts with combination therapy designed to target multiple steps in apoptotic pathways may not only improve the efficacy of TRAIL-mediated therapies, but may also improve quality of life for ovarian cancer patients by reducing toxicity associated with cancer therapy.
Tuesday, January 19, 2010
2010 full free access: The prosurvival activity of ascites against TRAIL is associated with a shorter disease-free interval in patients with ovarian c
( highly technical )The prosurvival activity of ascites against TRAIL is associated with a shorter disease-free interval in patients with ovarian cancer
Subscribe to:
Posts
(
Atom
)
